Within the type-based Single Lumen Tubing segmentation, product differentiation hinges on polymer performance and sterilization modality. PVC formulations retain the leading position on price and weldability, making them the default for high-throughput IV lines, yet they face headwinds from phthalate-free legislation. Polyurethane tubing is gaining share where kink resistance and thin walls translate into smaller outer diameters, a decisive factor in neonatal and ambulatory pumps. Silicone variants occupy a specialist tier, tolerating repeated autoclave cycles and aggressive drug chemistries, justifying a 3–4× price premium. TPE (thermoplastic elastomer) grades sit between PVC and silicone, offering hospitals a recyclable, latex-free pathway that aligns with Scope 3 emission targets. Analytical sourcing data show that procurement managers balance unit cost against total cost of ownership—sterilization, disposal, and liability—so the type mix shifts measurably toward higher-performance polymers when reimbursement bundles incentivize lower infection rates, underscoring the strategic value of granular market taxonomy.